No abstract available
MeSH terms
-
Angiogenesis Inhibitors / immunology*
-
Angiogenesis Inhibitors / therapeutic use*
-
Antibodies / therapeutic use
-
Antibodies, Monoclonal / immunology
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized / immunology
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
B7-H1 Antigen / immunology
-
Bevacizumab
-
Cancer Vaccines / therapeutic use
-
Clinical Trials as Topic
-
Humans
-
Immunosuppressive Agents / pharmacology
-
Immunotherapy* / methods
-
Ipilimumab
-
Neoplasms / drug therapy*
-
Neoplasms / immunology*
-
Vascular Endothelial Growth Factor A / immunology*
Substances
-
Angiogenesis Inhibitors
-
Antibodies
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
B7-H1 Antigen
-
CD274 protein, human
-
Cancer Vaccines
-
Immunosuppressive Agents
-
Ipilimumab
-
Vascular Endothelial Growth Factor A
-
Bevacizumab
-
pembrolizumab